21 related articles for article (PubMed ID: 1816872)
1. Applications of in vivo imaging in the evaluation of the pathophysiology of viral and bacterial infections and in development of countermeasures to BSL3/4 pathogens.
Bocan TM; Panchal RG; Bavari S
Mol Imaging Biol; 2015 Feb; 17(1):4-17. PubMed ID: 25008802
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the phytic acid effect on the labeling of blood elements with technetium-99m and on the survival of a strain of Escherichia coli treated with stannous fluoride.
Lima-Filho GL; Lima GM; Freitas RS; Aleixo LC; Moreno SR; Catanho MT; Bernardo-Filho M
Mol Cell Biochem; 2003 May; 247(1-2):121-6. PubMed ID: 12841639
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of technetium-99m decay on Escherichia coli inactivation: effects of physical or chemical agents.
Silva CR; Valsa JO; Caniné MS; Caldeira-de-Araújo A; Bernardo-Filho M
Yale J Biol Med; 1998; 71(1):7-14. PubMed ID: 9713950
[TBL] [Abstract][Full Text] [Related]
4. Conditions for labeling of Schistosoma mansoni cercaria with technetium-99m.
Bernardo Filho M; Machado e Silva JR; Reis Rde J; Boasquevisque EM; Hassón-Voloch A
J Nucl Biol Med (1991); 1992; 36(1):56-9. PubMed ID: 1450227
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations.
Welling MM; Paulusma-Annema A; Balter HS; Pauwels EK; Nibbering PH
Eur J Nucl Med; 2000 Mar; 27(3):292-301. PubMed ID: 10774881
[TBL] [Abstract][Full Text] [Related]
6. A propolis extract and the labeling of blood constituents with technetium-99m.
Jesus LM; Abreu PR; Almeida MC; Brito LC; Soares SF; de Souza DE; Bernardo LC; Fonseca AS; Bernardo-Filho M
Acta Biol Hung; 2006 Jun; 57(2):191-200. PubMed ID: 16841470
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m labeling of human monocytes for chemotactic studies.
Papierniak CK; Bourey RE; Kretschmer RR; Gotoff SP; Colombetti LG
J Nucl Med; 1976 Nov; 17(11):988-92. PubMed ID: 978262
[TBL] [Abstract][Full Text] [Related]
8. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
Vilcek S; Kalincák M; Machán V
Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
[TBL] [Abstract][Full Text] [Related]
9. [Antibody radiolabeling with technetium-99m].
Perera A; Pérez C
Rev Esp Med Nucl; 1998; 17(4):302-9. PubMed ID: 9721347
[TBL] [Abstract][Full Text] [Related]
10. The influence of chelator on the pharmacokinetics of 99mTc-labelled peptides.
Decristoforo C; Mather SJ
Q J Nucl Med; 2002 Sep; 46(3):195-205. PubMed ID: 12134136
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m distribution into Klebsiella pneumoniae.
Bernardo-Filho M; Pereira JA; Boasquevisque EM; Hassón-Voloch A
J Nucl Biol Med (1991); 1991; 35(3):162-6. PubMed ID: 1816872
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
